DAB2IP and cancer: Among the many genes whose dysregulation impacts cancer evolution and drug sensitivity, the tumor-suppressor DAB2IP (Disabled-2 Interacting Protein), also known as AIP (ASK1-interacting protein AIP1) is particularly interesting as it can negatively modulate several major oncogenic pathways.